Johannesburg, South Africa - After three-year-old Isabella "Pippie" Kruger was burned on over 80% of her body in a tragic accident, her mother was left searching for a viable option to repair her extremely damaged skin and save her life.
The solution came from across the globe in the form of a company called Genzyme in Boston, MA. Genzyme has developed a protocol for cultivating autologous epidural stem cells in order to generate new skin for patients who have suffered extreme skin trauma.
Genzyme was able to graft 41 sheets of new skin that was made of Pippie's own genetic material. This was then flown across the world to South Africa, where the procedure of grafting her new skin took place. It was the first time this type of procedure was administered in South Africa.
Global collaboration in the administration of stem cell therapies to treat previously untreatable conditions is accelerating the paradigm shift in the medical community for the treatment of disease, trauma and injury; a shift that is spearheaded by the utilization of autologous stem cells. The use of the patient’s own stem cells in emerging regenerative therapies eliminates the chance of rejection of the transplanted tissue and the need for immuno-suppression drugs leading to more favorable outcomes.
To learn more about how families can bank their own valuable stem cells to ensure access to a variety of emerging regenerative treatments and therapies, visit www.stemsave.com or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The future of Regenerative Medicine is now.